Pancreatitis & Oesophageal Motility — MRCP Part 1
- Crack Medicine

- 1 hour ago
- 3 min read
TL;DR
This MRCP Part 1 guide covers high-yield concepts in pancreatitis scoring systems, chronic pancreatitis management, and oesophageal motility disorders (achalasia to spasm). Focus on prognostic scores (Glasgow, Ranson), complications, and manometry patterns. Expect exam traps around timing of scoring, enzyme interpretation, and differentiating motility disorders. Use this as a quick revision plus applied MCQ practice.
Why this matters
Pancreatitis and oesophageal motility disorders are consistently tested topics in MRCP Part 1. Questions often require interpretation of severity scores, recognition of complications, and differentiation between motility disorders based on investigation findings.
This guide complements your preparation alongside the MRCP Part 1 overview and targeted revision using Free MRCP MCQs.
Core sections
1. Acute Pancreatitis: Diagnosis & Key Concepts
Acute pancreatitis is diagnosed when two of the following three criteria are met:
Characteristic epigastric pain radiating to the back
Serum amylase or lipase ≥3 times normal
Imaging consistent with pancreatitis
Exam insights:
Lipase is more specific than amylase
Amylase may be normal in delayed presentation or hypertriglyceridaemia
2. Severity Scoring Systems (High-Yield)
Score | Timing | Key Features | Exam Tip |
Glasgow (Imrie) | 48 hours | PANCREAS mnemonic | Most tested in UK exams |
Ranson | Admission + 48 hours | Complex criteria | Less commonly used |
BISAP | Within 24 hours | Simple bedside tool | Increasing relevance |
Glasgow Criteria (PANCREAS):
PaO₂ <8 kPa
Age >55
Neutrophils raised
Calcium low
Renal function (urea raised)
Enzymes (LDH/AST raised)
Albumin low
Sugar raised
👉 Score ≥3 indicates severe pancreatitis
3. Complications of Acute Pancreatitis
Early complications:
SIRS
ARDS
Hypovolaemic shock
Late complications:
Pancreatic necrosis
Pseudocyst (>4 weeks)
Infection
Exam pearl:
Infected necrosis requires antibiotics and intervention
Sterile necrosis is managed conservatively
4. Chronic Pancreatitis: Management Principles
Common causes include alcohol, genetic mutations, and autoimmune disease.
Management strategy:
Stepwise analgesia
Pancreatic enzyme supplementation (e.g., Creon)
Fat-soluble vitamin replacement
Glycaemic control
Red flag: Unintentional weight loss or worsening pain may indicate pancreatic malignancy.
5. Achalasia (Classic MRCP Topic)
Achalasia is characterised by failure of lower oesophageal sphincter (LES) relaxation and absence of peristalsis.
Key features:
Progressive dysphagia (solids → liquids)
Bird-beak sign on barium swallow
Manometry: increased LES pressure, absent peristalsis
Management:
Pneumatic dilation
Heller myotomy
Botulinum toxin (frail patients)
6. Diffuse Oesophageal Spasm
Intermittent dysphagia and chest pain
Barium swallow: corkscrew oesophagus
Manometry: simultaneous contractions
Treatment:
Calcium channel blockers
Nitrates
7. Nutcracker Oesophagus
High-amplitude peristalsis
Chest pain predominant
Normal LES relaxation
8. Achalasia vs Spasm (Comparison Table)
Feature | Achalasia | Diffuse Spasm |
Peristalsis | Absent | Uncoordinated |
LES pressure | Increased | Normal |
Barium swallow | Bird-beak | Corkscrew |
Dysphagia | Progressive | Intermittent |
9. Investigation Strategy
First-line: Endoscopy (exclude malignancy)
Gold standard: Oesophageal manometry
Barium swallow: supportive
10. High-Yield Summary (Exam Recall)
Lipase is more specific than amylase
Glasgow score is assessed at 48 hours
Pseudocysts develop after 4 weeks
Alcohol is the most common cause of chronic pancreatitis
Achalasia shows failure of LES relaxation
Bird-beak sign is classic for achalasia
Manometry is diagnostic gold standard
Oesophageal spasm presents with chest pain
BISAP is an early severity score
Always exclude malignancy in dysphagia
Practical examples / mini-cases
MCQ: A 52-year-old man presents with severe epigastric pain and raised lipase. At 48 hours, his Glasgow score is 4. What is the significance?
Answer: Severe acute pancreatitis
Explanation: A Glasgow score ≥3 indicates severe disease and higher risk of complications, requiring close monitoring and aggressive management.

Common pitfalls
Applying Glasgow score at admission instead of 48 hours
Assuming normal amylase excludes pancreatitis
Misinterpreting pseudocyst timing
Missing malignancy in dysphagia presentations
Confusing achalasia with reflux disease
Practical study-tip checklist
Learn scoring systems using mnemonics (PANCREAS)
Focus on interpretation rather than memorisation
Practise with timed questions via Start a mock test
Integrate symptoms with investigations and management
Revise manometry findings visually
FAQs
1. Which scoring system is most important for MRCP Part 1?
Glasgow (Imrie) score is the most commonly tested system. Focus on its parameters and timing at 48 hours.
2. Is lipase always elevated in pancreatitis?
Lipase is more sensitive and specific than amylase, but may occasionally be normal depending on timing and cause.
3. What is the gold standard for diagnosing achalasia?
Oesophageal manometry is the gold standard, demonstrating absent peristalsis and raised LES pressure.
4. How can you differentiate achalasia from diffuse oesophageal spasm?
Achalasia shows absent peristalsis and bird-beak appearance, whereas spasm shows uncoordinated contractions and corkscrew oesophagus.
5. When should a pancreatic pseudocyst be suspected?
Typically after 4 weeks following acute pancreatitis, especially with persistent symptoms or mass effect.
Ready to start?
Consolidate your Gastroenterology preparation with structured resources and exam-focused practice. Start with the MRCP Part 1 overview, strengthen concepts using Free MRCP MCQs, and refine performance through mock tests. For deeper understanding, explore our lectures.
Sources
MRCP(UK) Examination Blueprint — https://www.mrcpuk.org/mrcpuk-examinations/part-1
NICE Guidelines: Acute Pancreatitis — https://www.nice.org.uk/guidance/ng104
British Society of Gastroenterology Guidelines — https://www.bsg.org.uk
Kumar & Clark Clinical Medicine



Comments